Dietary Supplements Blossom As Revenue Growth Ingredients For Big Pharma

Dwindling product pipelines are pushing pharmaceutical companies to look to dietary supplements for business opportunities, not only through product sales but also by using herbal substances to develop new drug ingredients

More from Archive

More from Pink Sheet